← Back to Clinical Trials
Recruiting NCT06411769

NCT06411769 Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06411769
Status Recruiting
Phase —
Sponsor University of Texas, El Paso
Condition Activity Trackers
Study Type INTERVENTIONAL
Enrollment 406 participants
Start Date 2024-09-01
Primary Completion 2027-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
50K4LIfeSMS Text MessagingIndividual

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 406 participants in total. It began in 2024-09-01 with a primary completion date of 2027-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The investigators will test if the 50,000 for Life (50K4Life) is effective at improving walking engagement in school employees in 30 public schools by delivering a two-phased adaptive intervention to improve walking engagement in school workers in 30 public schools. In Phase 1, all study schools will be randomly assigned to a 50K4Life only, or 50K4Life + SMS Text Messaging group. In Phase 2, non-responder schools will be randomly assigned to one of two 6-month adaptive treatments: a) an individual-level intervention that includes remote education modules (REM) and one-to-one monthly phone-based coaching, or, b) a school-level intervention that includes group educational sessions, school environmental modifications (floor distance markings, signage in corridors and breakrooms, promotional items), and work time/weekend group walks/hikes. The schools that 50% or more participants who achieve 50,000 steps in one week will continue with the Phase 1 condition. Intervention strategies will be coordinated by health educators and managed using the Pathverse app. Data collection will occur at baseline, 8 weeks (Phase 2 randomization decision point), 8 months (immediate post intervention), 12 months (4 months post-intervention), and 18 months (10 months post-intervention) for a total of 18 months of study participation.

Eligibility Criteria

Inclusion Criteria: * A school is eligible if it is located within one of the four target school districts * adult 18 years or older * full-time school-based school district employee * not pregnant and able to walk without physical limitations or assistive device * willing to wear our Fitbit tracking device or use their own tracking device for 18 months * own a smartphone * willingness to use a personal smartphone for tracking activity related to the Fitbit tracker, access online intervention content, and receive text messages. Exclusion Criteria: * Works at more than one school * Does not work on a district school campus * schools that previously participated in walking challenges

Contact & Investigator

Central Contact

Jennifer J Salinas, Ph.D.,LMSW

✉ jsalinas7@utep.edu

📞 915-747-7292

Principal Investigator

Jennifer J Salinas, Ph.D., LMSW

PRINCIPAL INVESTIGATOR

University of Texas, El Paso

Frequently Asked Questions

Who can join the NCT06411769 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Activity Trackers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06411769 currently recruiting?

Yes, NCT06411769 is actively recruiting participants. Contact the research team at jsalinas7@utep.edu for enrollment information.

Where is the NCT06411769 trial being conducted?

This trial is being conducted at El Paso, United States, El Paso, United States.

Who is sponsoring the NCT06411769 clinical trial?

NCT06411769 is sponsored by University of Texas, El Paso. The principal investigator is Jennifer J Salinas, Ph.D., LMSW at University of Texas, El Paso. The trial plans to enroll 406 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology